Skip to Main Content

Paper Details

A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
N Engl J Med
96
2021
Acute Myocarditis, CD4, CD4+, CD4+ T cells, Circulating MicroRNA, Th17 cells, acute myocardial infarction, acute myocarditis, autoimmune myocarditis, autoimmune or viral myocarditis, coxsackievirus, hsa, hsa-miR-, hsa-miR-Chr8, hsa-miR-Chr8:, hsa-miR-Chr8:96, human, humans, interleukin-17, mice, microRNA, microRNA mmu-miR-721, mmu, mmu-miR-721, myocardial infarction, myocarditis, patients, plasma, serum troponin, type 17 helper T (Th17) cells
Author NameAffiliation
Katelyn A BrunoInstituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Hospital Universitario 12 de Octubre, and Instituto de Investigacion Sanitaria Hospital 12 de Octubre (G.M., Hospital Ramon y Cajal (L.M.V.-G.), HM Hospitales-Centro Integral de Enfermedades Cardiovasculares (L.F.-F.), Hospital Universitario Central de Asturias, Hospital Universitario Virgen de la Arrixaca, Mayo Clinic, Massachusetts General Hospital, and Harvard Medical School, Hematology and Clinical Immunology (R.M.), University of Padua, Italy Charite Universitatsmedizin Berlin, Berlin (B.H.) Imperial College and Royal Brompton and Harefield Hospital, London (T.F.L.) and the Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
Mercedes RicoteInstituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Hospital Universitario 12 de Octubre, and Instituto de Investigacion Sanitaria Hospital 12 de Octubre (G.M., Hospital Ramon y Cajal (L.M.V.-G.), HM Hospitales-Centro Integral de Enfermedades Cardiovasculares (L.F.-F.), Hospital Universitario Central de Asturias, Hospital Universitario Virgen de la Arrixaca, Mayo Clinic, Massachusetts General Hospital, and Harvard Medical School, Hematology and Clinical Immunology (R.M.), University of Padua, Italy Charite Universitatsmedizin Berlin, Berlin (B.H.) Imperial College and Royal Brompton and Harefield Hospital, London (T.F.L.) and the Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
DeLisa FairweatherInstituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Hospital Universitario 12 de Octubre, and Instituto de Investigacion Sanitaria Hospital 12 de Octubre (G.M., Hospital Ramon y Cajal (L.M.V.-G.), HM Hospitales-Centro Integral de Enfermedades Cardiovasculares (L.F.-F.), Hospital Universitario Central de Asturias, Hospital Universitario Virgen de la Arrixaca, Mayo Clinic, Massachusetts General Hospital, and Harvard Medical School, Hematology and Clinical Immunology (R.M.), University of Padua, Italy Charite Universitatsmedizin Berlin, Berlin (B.H.) Imperial College and Royal Brompton and Harefield Hospital, London (T.F.L.) and the Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
Valentin FusterInstituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Hospital Universitario 12 de Octubre, and Instituto de Investigacion Sanitaria Hospital 12 de Octubre (G.M., Hospital Ramon y Cajal (L.M.V.-G.), HM Hospitales-Centro Integral de Enfermedades Cardiovasculares (L.F.-F.), Hospital Universitario Central de Asturias, Hospital Universitario Virgen de la Arrixaca, Mayo Clinic, Massachusetts General Hospital, and Harvard Medical School, Hematology and Clinical Immunology (R.M.), University of Padua, Italy Charite Universitatsmedizin Berlin, Berlin (B.H.) Imperial College and Royal Brompton and Harefield Hospital, London (T.F.L.) and the Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 4

Datasets

Release 1.2